Aurora Cannabis Inc. (TSE:ACB – Get Free Report)’s share price was down 2.6% during mid-day trading on Wednesday. The stock traded as low as C$5.42 and last traded at C$5.56. Approximately 406,437 shares changed hands during mid-day trading, a decline of 1% from the average daily volume of 410,680 shares. The stock had previously closed at C$5.71.
Analysts Set New Price Targets
A number of brokerages recently commented on ACB. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Canaccord Genuity Group reduced their target price on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. ATB Cormark Capital Markets cut shares of Aurora Cannabis from an “outperform” rating to a “tender” rating and lowered their price target for the stock from C$6.50 to C$5.60 in a research report on Wednesday, August 19th. Finally, TD dropped their price target on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of C$6.20.
View Our Latest Stock Analysis on Aurora Cannabis
Aurora Cannabis Trading Down 0.4%
Aurora Cannabis (TSE:ACB – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The firm had revenue of C$67.55 million during the quarter. Research analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.
Aurora Cannabis Company Profile
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Saddle Up: Texas Stock Exchange Ropes In $80 Billion in Listings
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
